Urolithin A vs Ergothioneine

Reviewed by SOMA HEALTH's Medical Research Team

Urolithin A and ergothioneine both show up on lists of promising healthy-aging compounds, and both are made or absorbed through the diet rather than manufactured by the body on demand. But they work in genuinely different ways: urolithin A is studied for supporting mitophagy, the recycling of worn-out mitochondria, while ergothioneine is a diet-derived antioxidant often called a ‘longevity vitamin.’ Here is a careful look at what separates them and where each one currently stands on evidence.

The core difference in one line

Urolithin A supports a maintenance process; ergothioneine acts as a protective molecule. Mitophagy is your cells’ way of clearing out damaged mitochondria so healthier ones can carry the load, and urolithin A is one of the few dietary compounds shown to engage it. Ergothioneine, by contrast, is a naturally occurring antioxidant that your body actively accumulates in tissues and appears to use to help buffer oxidative stress. One is about cleaning up worn parts; the other is about shielding parts from damage in the first place.

If you are still getting oriented to the first compound, our complete urolithin A guide is the best starting point, and the primer on mitochondrial health explains why the mitochondria sit at the center of so much of this conversation.

What ergothioneine is

Ergothioneine is a sulfur-containing amino-acid derivative that humans do not synthesize. We obtain it from food, most notably mushrooms; oyster, shiitake, maitake and porcini varieties are especially rich sources, and smaller amounts appear in beans, oat bran and organ meats. What makes ergothioneine unusual is that the body has a dedicated transporter (often referred to as OCTN1) that pulls it into cells and concentrates it in tissues exposed to oxidative stress. Scientists generally read the existence of a specific transporter as a hint that a nutrient plays some physiological role, which is part of why the biochemist Bruce Ames grouped it among candidate ‘longevity vitamins’ — nutrients that are not classically essential in the way vitamin C is, but that may support long-term health.

What the evidence for ergothioneine looks like

It is important to be candid here: much of the human evidence for ergothioneine is observational rather than interventional. Population studies have noted that lower blood levels of ergothioneine tend to track with frailty and various age-related conditions, and laboratory work shows clear antioxidant and cytoprotective activity. What is thinner is the set of large, randomized human trials demonstrating that supplementing ergothioneine changes meaningful outcomes. So while the mechanistic story and the epidemiology are intriguing, the compound sits earlier on the human-evidence curve than its enthusiastic marketing sometimes implies. Ergothioneine is a nutrient of interest, not a treatment for any disease.

What urolithin A is

Urolithin A is a postbiotic. Your gut bacteria produce it when they metabolize ellagitannins, the polyphenols found in pomegranates, walnuts and certain berries. There is a wrinkle that makes direct supplementation appealing: only some people carry the microbial machinery needed to convert those polyphenols into meaningful amounts of urolithin A, so eating the source foods does not guarantee you actually generate the compound. Taking it directly delivers a consistent dose.

Its studied mechanism is support for mitophagy. Mitochondria are the energy-producing structures inside your cells, and over time they accumulate damage. Mitophagy is the recycling program that tags and clears the worn ones so the cell can maintain a healthier population. This process tends to become less efficient with age, and urolithin A is notable for engaging it through the diet.

Proven human evidence for urolithin A

The human record starts with Andreux and colleagues (2019, Nature Metabolism), the first-in-human study, which found urolithin A safe and well tolerated at doses up to 1,000 mg per day and identified a mitochondrial gene-expression signature. Liu and D’Amico and colleagues (2022, JAMA Network Open) studied older adults over about four months and reported effects on muscle endurance. Singh and colleagues (2022, Cell Reports Medicine) tested 500 mg and 1,000 mg arms in middle-aged adults over four months, with benefits observed for muscle strength and exercise performance.

Newer human evidence

The picture has continued to fill in. A 2025 randomized controlled trial in Nature Aging (roughly 28 days) reported that urolithin A supported the mitochondrial health of immune cells in midlife adults, a theme tied to inflammaging. A 2024 trial in the Journal of the International Society of Sports Nutrition ran eight weeks in resistance-trained men, and a 2025 trial looked at distance runners. The honest summary, echoing the 2024 systematic review in Ageing Research Reviews, is that this is a promising and expanding but still-emerging body of human work.

Preclinical urolithin A research

The foundational mechanistic findings come from laboratory studies that should be labeled preclinical. Ryu and colleagues (2016, Nature Medicine) showed mitophagy, extended lifespan in the worm C. elegans, and muscle benefits in rodents. D’Amico and colleagues (2022, Aging Cell) examined joint and cartilage outcomes in osteoarthritis models. Directions such as skin, gut, brain and heart remain early and exploratory, where preclinical research is investigating possibilities not yet confirmed in people.

Mitophagy vs antioxidant: complementary, not competing

The most useful way to hold these two together is to notice that they address different problems. An antioxidant like ergothioneine works to neutralize reactive oxygen species and limit oxidative damage. Mitophagy, the process urolithin A supports, is a step downstream and different in kind: it removes mitochondria that have already become dysfunctional. Reducing damage and recycling what is already damaged are not the same task, and there is no reason to expect the two to substitute for each other. In principle they operate on different levers of cellular resilience.

That said, the confidence you can place in each differs. Urolithin A has a series of published randomized human trials behind specific structure/function claims around muscle and mitochondrial biology. Ergothioneine’s human story leans more heavily on observational data and mechanism. Neither is a shortcut to health, and neither treats disease, but when weighing the two it is fair to say urolithin A currently has the more developed set of human trials.

Dosing and practical guidance

Urolithin A has been studied at 500 to 1,000 mg per day, with 1,000 mg at the top of the range; that is the amount SOMA HEALTH Urolithin A Gummies are built around, and our dosage page covers the details. Ergothioneine does not have an established supplemental dose in the way a vitamin does; intakes in research vary, and much of the interest centers on simply eating more mushrooms, which is a low-risk way to raise dietary intake. Because ergothioneine research is still early, treat any specific supplemental dose claims with healthy skepticism and check the current label.

Neither compound is a treatment for any medical condition. If you are managing an age-related concern, immune question or anything else, these ingredients are not a substitute for medical care. Talk with a qualified healthcare provider before starting either, particularly if you take medication or have a health condition.

So which one?

If your priority is supporting mitochondrial quality control with the benefit of published human trials, urolithin A is the more evidence-backed choice today, and direct supplementation solves the microbiome conversion problem that food cannot. If you are drawn to ergothioneine, the lowest-risk move is often to eat more mushrooms rather than chase a supplement whose human trial base is still thin. And because their mechanisms differ, they are not mutually exclusive. If you want to compare specific urolithin A products before deciding, our guide to the best urolithin A gummies lays out dose, testing and value side by side.

Shop SOMA HEALTH Urolithin A Gummies

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This guide is educational and is not a substitute for advice from a qualified healthcare provider.